Janssen R&D Establishes Mobile Medication and Data Management Tech Platform

Article

Applied Clinical Trials

Janssen Research & Development announced that it has created the Integrated Smart Trial & Engagement Platform, an information technology toolset developed to automate investigational product supply and data management in clinical trials. The platform is designed to replace the paper-based conventional processes of managing clinical supplies and tracking patient health data.

Read the full release here.

Recent Videos
Related Content
Credit: Araki Illustrations | stock.adobe.com. FDA Panel Votes Against Columvi-GemOx sBLA

FDA Panel Votes Against Columvi-GemOx sBLA for R/R DLBCL Over Regional Data Concerns from STARGLO Trial

Davy James
May 21st 2025
Article

The FDA’s Oncologic Drugs Advisory Committee voted against an application for Columvi (glofitamab) plus GemOx for relapsed/refractory diffuse large B-cell lymphoma due to concerns about the applicability of multiregional trial data to the US patient population.

Unifying Industry to Better Understand GCP Guidance

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
May 7th 2025
Podcast

In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.

© photon_photo - © photon_photo - stock.adobe.com

Less is More in Clinical Data: The Road to Simpler and Better Trials

Drew Garty
May 20th 2025
Article

A pragmatic approach to streamlining technology and innovating processes will help advance clinical data management.

Site Logo

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

May 2nd 2025
Podcast
© putilov_denis - © putilov_denis - stock.adobe.com

Advancing Patient Engagement in Community-Based Oncology Research

Katie Celentino, DNP, RN, CMSRN
May 19th 2025
Article

Improving access while maintaining a high level of research.

Credit: Johannes | stock.adobe.com. View of cancerous squamous cell carcinoma in the esophagus through a microscope. Concept Medical Imaging, Cancer Research, Squamous Cell Carcinoma, Esophageal Diseases

Merck and Daiichi Sankyo Launch Global Phase III Trial of Novel Antibody Drug Conjugate in Advanced Esophageal Squamous Cell Carcinoma

Davy James
May 19th 2025
Article

The global, randomized IDeate-Esophageal01 study will evaluate ifinatamab deruxtecan, a B7-H3–targeted antibody-drug conjugate, versus physician’s choice of chemotherapy in patients with advanced or metastatic esophageal squamous cell carcinoma following progression on platinum-based chemotherapy and immune checkpoint inhibitors.

© 2025 MJH Life Sciences

All rights reserved.